Opinion|Videos|September 20, 2024
The Future of CLL Care: Medical Breakthroughs and Patient-Physician Collaboration
The discussion will wrap up with perspectives on the future of CLL treatment, including anticipated improvements in patient care and quality of life, emerging therapies, and evolving patient roles in care decisions.
Advertisement
Episodes in this series
Video content above is prompted by the following:
Let’s conclude by discussing our perspectives on the future of CLL treatment.
- How do you envision the CLL patient experience evolving in the coming years? What improvements in care and quality of life do you hope to see? How do you hope emerging therapies and research will address these gaps?
- Based on your experience, what excites you most about the future of CLL management? How do you think the role of patients in their care decisions will continue to evolve?
Advertisement
Related to this article
Medicare will move ostomy supplies to eight national contracts in 2028. Survivors and clinicians say a poor fit can lead to leaks, infection and hospital stays.
An experimental treatment has kept one patient with heavily pretreated hairy cell leukemia free of detectable disease for more than two years, raising questions about whether CAR T-cell therapy could offer a path toward a cure.
The National Comprehensive Cancer Network released its first patient guideline written for caregivers on Oct. 27, 2026. The free guide covers emotional support, money, legal questions, medical tasks and caregivers' own well-being.
Three phase 3 trials presented at the 2026 ESMO Congress looked closely at swallowing, daily functioning and blood counts in throat, kidney and colorectal cancer. Here is what they found about living well during and after treatment.
New research found that nearly 1 in 5 second-level appeals for denied cancer medications under Medicare Part D were successful, raising questions about how insurers make coverage decisions and what patients can do when their treatment is denied.
Joy Maulik, MSN, FNP-C, explains why a prostate cancer diagnosis should be seen as a change in direction, not an ending, and how patients can lean on education, their providers and caregivers.
Dr. Morana Vojnic answers common questions about brain cancer, including diagnosis, tumor types, treatment effects, recurrence and life after treatment begins.
A national survey study of about 200,000 adults, published in Supportive Care in Cancer, found that people caring for someone with cancer had 89% higher odds of frequent mental distress than people who were not caregivers.
Advertisement
Advertisement
Trending on CURE
1
Medicare to Cut Ostomy Suppliers to 8 Contracts: What Patients Need to Know
2
3 ESMO 2026 Results in Endometrial and Breast Cancer to Know
3
3 Quality-of-Life Results From ESMO 2026 Patients Should Know
4
4 Long-Term Survival Results From ESMO 2026 Patients Should Know
5